You searched Hervé Avet- Loiseau - Toulouse Cancer Research Center

Hervé Avet-Loiseau among the most influential researchers in 2019

Nov 27, 2019 | Unclassified

Prof. Hervé Avet-Loiseau, head of the "Myeloma Genomics" unit at IUCT-Oncopole and the "Oncogenomics and immunology of myeloma" team at CRCT is on Clarivate Analytics' list of the most influential researchers of the past decade. This is a prestigious recognition of...

Hervé Avet-Loiseau awarded with FRM Prize Rosen 2017

Nov 29, 2017 |

Pr. Hervé Avet-Loiseau, Director of CRCT's team 13 "Pharmacogenomics of multiple myeloma" and Director of IUCT-O's Unit "Genomics of Myeloma" is laureate of the 2017 Prize Rosen from the Fondation pour la Recherche Médicale (FRM) More information here.

The ARC Foundation supports CRCT’s team 13 (Hervé Avet-Loiseau) with 400 000€

Nov 28, 2017 |

Better target the tumor and its immune environment to defeat multiple myeloma The ARC Foundation awarded a grant of 400,000 euros to Professor Hervé Avet-Loiseau for his work on multiple myeloma, the second most common malignant hemopathy (blood cancer), with more...

Focus research 2022 GENIM team

Oct 2, 2023 | Discover GENIM

Focus research 2022 GENIM teamRobert A. Kyle Achievement Award In June 2022, Prof. Hervé Avet-Loiseau was awarded the prestigious Robert A. Kyle Achievement Award by the International Myeloma Foundation (IMF) for his major contribution to the study of myeloma. The...

Cancer: a key mechanism for improving immunotherapies identified by a Toulouse team

Jun 30, 2023 | Discover GENIM, Discover home page

Cancer: a key mechanism for improving immunotherapies identified by a Toulouse teamCancer, Immunology,Immunotherapy,Lymphocytes,Depletion.Ludovic Martinet Team GENIM Genomic and immunology of myeloma A team from the Centre de Recherches en Cancérologie de Toulouse,...

1st Young Scientist Cancer Congress (YS2C)

Apr 21, 2023 | Unclassified

1st Young Scientist Cancer Congress (YS2C) New research strategies for cancer therapy – from bench to bedside October 05, 2023 - Toulouse FranceThe CRCT postdocs association was created in 2022 by Benoît Aliaga, Chloé Bessière and Steffen Fuchs. It gathers the 31...

A new target to fight certain aggressive leukaemias

Apr 4, 2023 | Discover home page, Discover METAML

A new target to fight certain aggressive leukaemias Acute Myeloid Leukemia,FLT3,C/AAT-enhancer binding protein α,Jean-Emmanuel Sarry Team METAML- Metabolism and Therapeutic Resistance In Acute Myeloid Leukemia .Researchers from the Toulouse Cancer Research Centre and...

Top 5 CRCT publications for the year 2022

Feb 20, 2023 | Discover home page

The CRCT presents its Top 5 publications from its teams in 2022. Find all the 2022 publications of each team on their dedicated page.Filali, Liza, Marie-Pierre Puissegur, Kevin Cortacero, Sylvain Cussat-Blanc, Roxana Khazen, Nathalie, Van Acker, François-Xavier...

Heterogeneity in long-term outcomes for R-ISS stage II in newly diagnosed multiple myeloma patients

Oct 5, 2022 | Discover GENIM, Discover home page

Heterogeneity in long-term outcomes for R-ISS stage II in newly diagnosed multiple myeloma patientsMultiple myeloma,Cytogenetics,PrognosisAnaïs Schavgoulidze - Team GENIM - Genomic and Immunology of myelomaMultiple myeloma (MM) is characterized by clonal accumulation...

Teams

Jan 5, 2022 |

The 18 CRCTteamsT2i : Anti-tumour immunity and immunotherapyMaya AYYOUB, Jean-Pierre DELORDand 16 collaborators Deciphering the molecular and cellular mechanisms of tumour sensitivity/resistance to immunotherapy in order to design combined therapies capable of...

Pin It on Pinterest